Gene · 580
Papers4,139
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 4,139
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The promising role of new molecular biomarkers in prostate cancer: from coding and non-coding genes to artificial intelligence approaches. | Prostate Cancer Prostatic Dis | 2022 | 35422101 | PubTator, text mining | PubMed |
| Global characterization of extrachromosomal circular DNAs in advanced high grade serous ovarian cancer. | Cell Death Dis | 2022 | 35418185 | PubTator, text mining | PubMed |
| Recurrent Acromegaly in a Patient With a CHEK2 Mutation. | AACE Clin Case Rep | 2022 | 35415223 | PubTator, text mining | PubMed |
| Precision Combination Therapies Based on Recurrent Oncogenic Coalterations. | Cancer Discov | 2022 | 35412613 | PubTator, text mining | PubMed |
| Mutational Analysis of BRCA1 and BRCA2 Genes in Breast Cancer Patients from Eastern Sicily. | Cancer Manag Res | 2022 | 35411189 | PubTator, text mining | PubMed |
| The Interplay between PARP Inhibitors and Immunotherapy in Ovarian Cancer: The Rationale behind a New Combination Therapy. | Int J Mol Sci | 2022 | 35409229 | PubTator, text mining | PubMed |
| BRCA1/2 Serves as a Biomarker for Poor Prognosis in Breast Carcinoma. | Int J Mol Sci | 2022 | 35409110 | PubTator, text mining | PubMed |
| The Next Frontier: Translational Development of Ubiquitination, SUMOylation, and NEDDylation in Cancer. | Int J Mol Sci | 2022 | 35408841 | PubTator, text mining | PubMed |
| HuR Plays a Role in Double-Strand Break Repair in Pancreatic Cancer Cells and Regulates Functional BRCA1-Associated-Ring-Domain-1(BARD1) Isoforms. | Cancers (Basel) | 2022 | 35406624 | PubTator, text mining | PubMed |
| Advanced Bile Duct Cancers: A Focused Review on Current and Emerging Systemic Treatments. | Cancers (Basel) | 2022 | 35406572 | PubTator, text mining | PubMed |
| Tumor BRCA Testing in Epithelial Ovarian Cancers: Past and Future-Five-Years' Single-Institution Experience of 762 Consecutive Patients. | Cancers (Basel) | 2022 | 35406410 | PubTator, text mining | PubMed |
| Inducible degradation of dosage compensation protein DPY-27 facilitates isolation of Caenorhabditis elegans males for molecular and biochemical analyses. | G3 (Bethesda) | 2022 | 35404452 | PubTator, text mining | PubMed |
| Proof-of-Concept Pilot Study on Comprehensive Spatiotemporal Intra-Patient Heterogeneity for Colorectal Cancer With Liver Metastasis. | Front Oncol | 2022 | 35402285 | PubTator, text mining | PubMed |
| Rates of Variants of Uncertain Significance Among Patients With Breast Cancer Undergoing Genetic Testing: Regional Perspectives. | Front Oncol | 2022 | 35402282 | PubTator, text mining | PubMed |
| Altered Signaling Pathways Revealed by Comprehensive Genomic Profiling in Patients With Unknown Primary Tumors. | Front Oncol | 2022 | 35402276 | PubTator, text mining | PubMed |
| Multi-omics data integration analysis identifies the spliceosome as a key regulator of DNA double-strand break repair. | NAR Cancer | 2022 | 35399185 | PubTator, text mining | PubMed |
| The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma. | Clin Cancer Res | 2022 | 35398881 | PubTator, text mining | PubMed |
| Evaluating breast cancer predisposition genes in women of African ancestry. | Genet Med | 2022 | 35396981 | PubTator, text mining | PubMed |
| A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782). | Cancer Med | 2022 | 35396812 | PubTator, text mining | PubMed |
| Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancer. | NPJ Breast Cancer | 2022 | 35393462 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/580/papers?page=58